Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms
... disadvantages. Accordingly, solid SEDDS (S-SEDDS), prepared by solidification of liquid/semisolid selfemulsifying (SE) ingredients into powders, have gained popularity. This article gives an overview of the recent advances in the study of S-SEDDS, especially the related solidification techniques and ...
... disadvantages. Accordingly, solid SEDDS (S-SEDDS), prepared by solidification of liquid/semisolid selfemulsifying (SE) ingredients into powders, have gained popularity. This article gives an overview of the recent advances in the study of S-SEDDS, especially the related solidification techniques and ...
Articles - The Vespiary
... receptors. Finally, agonist efficacy was assessed by measurement of phosphoinositide hydrolysis in NIH 3T3 cells expressing the rat 5-HT2A or 5-HT2C receptors. Although 1 fully substituted for LSD in the DD assays (ED50 ) 33.5 µmol/kg), neither 8 nor 9 substituted for LSD, with just 50% of the rats ...
... receptors. Finally, agonist efficacy was assessed by measurement of phosphoinositide hydrolysis in NIH 3T3 cells expressing the rat 5-HT2A or 5-HT2C receptors. Although 1 fully substituted for LSD in the DD assays (ED50 ) 33.5 µmol/kg), neither 8 nor 9 substituted for LSD, with just 50% of the rats ...
Gastroprotective activity of caryophyllene oxide: the role of nitric
... ingestion of certain substances, including nonsteroidal antiinflammatory drugs (NSAIDs), alcohol, tobacco and caffeine. Even normal acid secretion can cause ulceration if gastroprotective factors are overwhelmed (Jainu and Devi, 2006). Current treatment options for patients suffering from gastrointe ...
... ingestion of certain substances, including nonsteroidal antiinflammatory drugs (NSAIDs), alcohol, tobacco and caffeine. Even normal acid secretion can cause ulceration if gastroprotective factors are overwhelmed (Jainu and Devi, 2006). Current treatment options for patients suffering from gastrointe ...
Simultaneous Separation of Different Types of Amphetamine and
... the possibility of using the piperazine drugs as amphetamine substitutes, we have chosen to optimize a similar chiral CE separation to accommodate these new piperazine related drugs (23). Because the reported effects of these two classes of drugs are strikingly similar, this method will greatly bene ...
... the possibility of using the piperazine drugs as amphetamine substitutes, we have chosen to optimize a similar chiral CE separation to accommodate these new piperazine related drugs (23). Because the reported effects of these two classes of drugs are strikingly similar, this method will greatly bene ...
Pharm Chapter 15 [4-20
... Unlike focal seizures, which start at a collection of neurons, and then spreads Might not be any aura in primary generalized seizures The best understood primary generalized seizure is the absence seizure (aka petit mal seizure) o Absence seizures are characterized by sudden interruptions in conscio ...
... Unlike focal seizures, which start at a collection of neurons, and then spreads Might not be any aura in primary generalized seizures The best understood primary generalized seizure is the absence seizure (aka petit mal seizure) o Absence seizures are characterized by sudden interruptions in conscio ...
(HMG-CoA) Reductase Inhibitors
... There is no basis for limiting therapy duration for HMG-CoA reductase inhibitors as control of cholesterol and other coronary heart disease risk factors is a life-long process. 3.* Duplicative Therapy The use of two or more HMG-CoA reductase inhibitors in combination is not justified. Additional th ...
... There is no basis for limiting therapy duration for HMG-CoA reductase inhibitors as control of cholesterol and other coronary heart disease risk factors is a life-long process. 3.* Duplicative Therapy The use of two or more HMG-CoA reductase inhibitors in combination is not justified. Additional th ...
Design and Optimization of Sustained
... Depakine® (sustained-release divalproex from Sanofi), a well-known commercial sustained-release preparation of divalproex sodium, contains 500 mg of the active agent per dosage form (10). This controlled-release formulations provide desired therapeutic plasma concentration over 24 h (12). Oral susta ...
... Depakine® (sustained-release divalproex from Sanofi), a well-known commercial sustained-release preparation of divalproex sodium, contains 500 mg of the active agent per dosage form (10). This controlled-release formulations provide desired therapeutic plasma concentration over 24 h (12). Oral susta ...
Antinociceptive, anti-inflammatory and central nervous system
... immune system. It protects from antigens and initiates immune responses [5]. Anxiety is responsible for obstacle of everyday life as it is involved with fear, worry as well as restlessness of a person. It, associated with psychological and physiological state, is marked by cognitive, somatic, emotio ...
... immune system. It protects from antigens and initiates immune responses [5]. Anxiety is responsible for obstacle of everyday life as it is involved with fear, worry as well as restlessness of a person. It, associated with psychological and physiological state, is marked by cognitive, somatic, emotio ...
as zoledronic acid monohydrate
... oral hygiene). While receiving treatment, these patients should avoid invasive dental procedures, if possible, but should continue with regular dental cleaning and oral hygiene. For patients requiring oral surgery, there are no data available to suggest whether discontinuation of bisphosphonate trea ...
... oral hygiene). While receiving treatment, these patients should avoid invasive dental procedures, if possible, but should continue with regular dental cleaning and oral hygiene. For patients requiring oral surgery, there are no data available to suggest whether discontinuation of bisphosphonate trea ...
Other Feed Additives
... requires obtaining an investigational new animal drug (INAD) to test a product. • New animal drug Application( NADA) is required to market a product. • Clearance IS required to use feed additives. ...
... requires obtaining an investigational new animal drug (INAD) to test a product. • New animal drug Application( NADA) is required to market a product. • Clearance IS required to use feed additives. ...
Modern Methods in Drug Discovery
... medicine (which drug and at what dosage), esp. for long term application of certain drugs (hypertension, analgesics, anti-psychotics) and those that possess a narrow ...
... medicine (which drug and at what dosage), esp. for long term application of certain drugs (hypertension, analgesics, anti-psychotics) and those that possess a narrow ...
POLYTRIM® Prescribing Information
... human dose. In some rabbit studies, the overall increase in fetal loss (dead and resorbed and malformed conceptuses) was associated with oral doses 6 times the human therapeutic dose. While there are no large well-controlled studies on the use of trimethoprim in pregnant women, Brumfitt and Pursell, ...
... human dose. In some rabbit studies, the overall increase in fetal loss (dead and resorbed and malformed conceptuses) was associated with oral doses 6 times the human therapeutic dose. While there are no large well-controlled studies on the use of trimethoprim in pregnant women, Brumfitt and Pursell, ...
11. Hormones of the sexual glands
... Issue – amp. 1,0 and 5,0 % solution in oil. Omnadren – oil solution for injection amp. 1 ml №5 (contains a mixture of testosterone esters: propionate, phenylpropionate, ...
... Issue – amp. 1,0 and 5,0 % solution in oil. Omnadren – oil solution for injection amp. 1 ml №5 (contains a mixture of testosterone esters: propionate, phenylpropionate, ...
FORMULATION AND EVALUATION OF OLMESARTAN MEDOXOMIL FLOATING TABLETS
... The composition of different formulations of Olmesartan Medoxomil floating tablets is shown in table 1. Direct compression method had been employed to prepare floating tablets of Olmesartan Medoxomil with hydroxyl propyl methyl cellulose (HPMC K4M, HPMC K100LV &HPMC E50LV), sodium alginate and carra ...
... The composition of different formulations of Olmesartan Medoxomil floating tablets is shown in table 1. Direct compression method had been employed to prepare floating tablets of Olmesartan Medoxomil with hydroxyl propyl methyl cellulose (HPMC K4M, HPMC K100LV &HPMC E50LV), sodium alginate and carra ...
Injectable Soft-Tissue Fillers: Clinical Overview
... skin is theoretically helpful in wrinkle reduction. Hyaluronic acid can be rather rapidly degraded and is ultimately metabolized in the liver. Modern processing methods have produced more stable forms of hyaluronic acid that have much longer in vivo retention times. As degradation occurs over time, ...
... skin is theoretically helpful in wrinkle reduction. Hyaluronic acid can be rather rapidly degraded and is ultimately metabolized in the liver. Modern processing methods have produced more stable forms of hyaluronic acid that have much longer in vivo retention times. As degradation occurs over time, ...
HIGHLIGHTS OF PRESCRIBING INFORMATION
... patients in Europe and Canada. Over 2,900 patients were treated in long-term studies for up to 6-12 months. In general, NEXIUM was well tolerated in both short and long-term clinical trials. The safety of NEXIUM was evaluated in 316 pediatric and adolescent patients aged 1 to 17 years in four clinic ...
... patients in Europe and Canada. Over 2,900 patients were treated in long-term studies for up to 6-12 months. In general, NEXIUM was well tolerated in both short and long-term clinical trials. The safety of NEXIUM was evaluated in 316 pediatric and adolescent patients aged 1 to 17 years in four clinic ...
Orally disintegrating tablets - Journal of Applied Pharmaceutical
... the lips, cheek, tongue, hard palate, soft palate and floor of the mouth (Fig. 1). The lining of the oral cavity is referred to as the oral mucosa, and includes the buccal, sublingual, gingival, palatal and labial mucosa. The buccal, sublingual and the mucosal tissues at the ventral surface of the t ...
... the lips, cheek, tongue, hard palate, soft palate and floor of the mouth (Fig. 1). The lining of the oral cavity is referred to as the oral mucosa, and includes the buccal, sublingual, gingival, palatal and labial mucosa. The buccal, sublingual and the mucosal tissues at the ventral surface of the t ...
Antifilarial Lead Molecules Isolated from Trachyspermum ammi
... bancrofti, Brugia malayi and B. timori, transmitted by mosquito vectors. The drugs currently used for lymphatic filariasis include annual doses of the microfilaricidal drug DEC (diethylcarbamazine), DEC plus albendazole, ivermectin plus albendazole or the use of DEC fortified salt [1]. None of these ...
... bancrofti, Brugia malayi and B. timori, transmitted by mosquito vectors. The drugs currently used for lymphatic filariasis include annual doses of the microfilaricidal drug DEC (diethylcarbamazine), DEC plus albendazole, ivermectin plus albendazole or the use of DEC fortified salt [1]. None of these ...
PDF - Journal of Nanobiotechnology
... FNB-loaded SDPs, NLCs and SMEDDS were prepared and their in vitro and in vivo properties were compared. SDPs significantly increased the release of FNB in medium with and without lipase, which is similar to the characteristics of Lipanthyl® capsules. Pancreatic lipase improved the release of FNB fro ...
... FNB-loaded SDPs, NLCs and SMEDDS were prepared and their in vitro and in vivo properties were compared. SDPs significantly increased the release of FNB in medium with and without lipase, which is similar to the characteristics of Lipanthyl® capsules. Pancreatic lipase improved the release of FNB fro ...
Triphala
... used in the ailments of all dosas, stimulates digestive capacity, rasayana and vrisya etc. It is a polyherbal compound. It is necessary to corroborate the consistency of mixing or combining in attribute balance. As per Ayurvedic Formulary of India (AFI) it is prepared by combining a 1:1:1 mixing of ...
... used in the ailments of all dosas, stimulates digestive capacity, rasayana and vrisya etc. It is a polyherbal compound. It is necessary to corroborate the consistency of mixing or combining in attribute balance. As per Ayurvedic Formulary of India (AFI) it is prepared by combining a 1:1:1 mixing of ...
13th Lecture 1436
... A primary action of isoniazid is to inhibit the biosynthesis of mycolic acids, which are long, branched lipids that are attached to a unique polysaccharide, arabino galactan, to form part of the mycobacterial cell wall Mycolic acids are unique to mycobacteria, explaining the high degree of selec ...
... A primary action of isoniazid is to inhibit the biosynthesis of mycolic acids, which are long, branched lipids that are attached to a unique polysaccharide, arabino galactan, to form part of the mycobacterial cell wall Mycolic acids are unique to mycobacteria, explaining the high degree of selec ...
anti-seizure medication review - Idaho Society of Health
... • Drug interactions should always be screen when starting AED therapy or adding a medication for a patient already ...
... • Drug interactions should always be screen when starting AED therapy or adding a medication for a patient already ...
A PRELIMINARY ANTIHYPERGLYCEMIC AND ANTINOCICEPTIVE ACTIVITY EVALUATION OF CAMPANULATUS
... corms of A. campanulatus, has the potential of acting synergistically and producing a strong antihyperglycemic effect, as has been observed in the present study with oral glucose tolerance tests. The presence of lupeol, stigmasterol, and -sitosterol in corms can also explain the observed antinocice ...
... corms of A. campanulatus, has the potential of acting synergistically and producing a strong antihyperglycemic effect, as has been observed in the present study with oral glucose tolerance tests. The presence of lupeol, stigmasterol, and -sitosterol in corms can also explain the observed antinocice ...
Antibiotics
... Clinical Trials • patient - has a diagnosed infection - two possibilities: – a) the new drug is the drug of choice by testing – b) the patient has not responded to other drugs and the new drug is testing well in the lab ...
... Clinical Trials • patient - has a diagnosed infection - two possibilities: – a) the new drug is the drug of choice by testing – b) the patient has not responded to other drugs and the new drug is testing well in the lab ...
Covalent inhibitors in drug discovery: from accidental discoveries to
... metabolites are covalent inhibitors such as omeprazole and lansoprazole (proton pump inhibitors) [13], and clopidogrel (antiplatelet) (Fig. 3) [14]. Today, there are at least 42 approved covalent drugs used to treat ailments ranging from obesity to aggressive malignancies [4]. Although most covalent ...
... metabolites are covalent inhibitors such as omeprazole and lansoprazole (proton pump inhibitors) [13], and clopidogrel (antiplatelet) (Fig. 3) [14]. Today, there are at least 42 approved covalent drugs used to treat ailments ranging from obesity to aggressive malignancies [4]. Although most covalent ...
Discovery and development of proton pump inhibitors
Proton pump inhibitors (PPIs) block the gastric hydrogen potassium ATPase (H+,K+-ATPase) and inhibit gastric acid secretion. These drugs have emerged as the treatment of choice for acid-related diseases, including gastroesophageal reflux disease (GERD) and peptic ulcer disease.PPIs also can bind to other types of proton pumps such as those that occur in cancer cells and are finding applications in the reduction of cancer cell acid efflux and reduction of chemotherapy drug resistance.